BioSpace News Archive

Getinge has been rewarded a product design award for its Maquet PowerLED II from the renowned Red Dot Award organization.

Merchant processor Fortress Payment Technologies recently notified all their e-Commerce customers selling CBD products that they would no longer be able to process Visa payments through their bank

The Medicines Company (NASDAQ:MDCO) will host a conference call and webcast for investors on Saturday, May 18, 2019, at 5:30 p.m. EDT.

In recognition of Lupus Awareness Month and World Lupus Day, Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH/TSX:AUP) (the “Company”) a late clinical-stage biopharmaceutical company with ongoing research in lupus nephritis (“LN”), today recognized World Lupus Day and Lupus Awareness Month with the launch of awareness and educational initiatives to support people with LN and Systemic Lupus Erythematosus (“SLE”):

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today data from two pilot studies on the use of its SkinTE™ product both showing successful closure of diabetic foot ulcers (DFUs) and venous stasis leg ulcers (VLUs) within a 12-week period.

ESSA Pharma Inc. (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal second quarter ended March 31, 2019.

Catalyst Health Ventures was announced as the winner for Healthcare Fund of the Year at ‘The 007th Annual NEVY Awards’, hosted by the New England Venture Capital Association and presented by Dell Technologies.

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that CEO Heather Bresch will present at the 2019 Bank of America Merrill Lynch Healthcare Conference in Las Vegas on Thursday, May 16, 2019 at 10:40 a.m. PT / 1:40 p.m. ET.

Divya Annamraju, Deputy Director of Strategy for Medical Devices Product Supply at Bayer, was honored as a Luminary by the Healthcare Businesswomen’s Association at its annual Woman of the Year event, Thursday, May 9, at the Marriott Marquis in New York.

BioTime, Inc., a clinical-stage biotechnology company developing cellular therapies for unmet medical needs, has been awarded a new research & development grant for 2019 of up to 9 million Israeli New Shekels from the Israel Innovation Authority.